US › Healthcare

Fractyl Health, Inc. Common Stock (GUTS)

US · Healthcare · Biotechnology

$0.69+1.15%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$9.2M
Profit YoY
+138.8%
EPS
$0.06
EPS estimate
$-0.41

EPS came in at 0.06 against a street estimate of -0.41 — a beat of 114.2%.

Key statistics

Market cap
$107.4M
Forward P/E
0.0
P/B
5.12
Book value
$0.14
EPS (TTM)
$-1.31
52-week high
$2.44
52-week low
$0.38
50-day MA
$0.79
200-day MA
$1.04
Beta
2.32

Analyst view

Analysts rate Fractyl Health, Inc. Common Stock a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $5.03.

Shareholding

Insiders
1.35%
Institutions
52.41%

Largest institutional holders

FundStake
Nantahala Capital Management, LLC8.42%
683 Capital Management LLC4.24%
Vanguard Group Inc3.80%
Pale Fire Capital SE3.73%
Vanguard Capital Management, LLC3.49%
Catalio Capital Management, LP3.46%
General Catalyst Group Management, LLC3.08%
Deer Management Co. LLC3.01%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Fractyl Health, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.